Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A BAF'ling Approach to Curing HIV.

Sakshi Tomar1, Ibraheem Ali1, Melanie Ott1

  • 1J. David Gladstone Institutes, 1650 Owens Street, San Francisco, CA 94158, USA; Department of Medicine, University of California, San Francisco, 1650 Owens Street, San Francisco, CA 94158, USA.

Cell Chemical Biology
|December 22, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cells.

bioRxiv : the preprint server for biology·2026
Same author

Climate Warming and Plant Disease: Mechanistic Insights Into Pathogenic Stress Resilience.

Plant, cell & environment·2026
Same author

AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.

Molecular cancer·2026
Same author

Self-Dimerization Induced Proximity Targeting Chimeras (SDIPTAC) Lead to DCAF1 Loss of Function and Inhibition of HIV Replication.

Journal of medicinal chemistry·2026
Same author

Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential.

Cell host & microbe·2026
Same author

Industrial Perspective on the Manufacturing of Lipid Nanoparticles for Nucleic Acid Delivery.

Pharmaceutics·2026

Researchers developed new compounds that target the BAF chromatin remodeling complex to reverse HIV-1 latency. This breakthrough offers potential for a functional cure for the virus.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • HIV-1 latency, where the virus remains dormant, is a major obstacle to developing a cure.
  • Current antiretroviral therapies suppress the virus but do not eliminate it due to latent reservoirs.

Purpose of the Study:

  • To identify and develop novel compounds capable of reversing HIV-1 latency.
  • To investigate the potential of targeting the BAF chromatin remodeling complex for HIV-1 cure strategies.

Main Methods:

  • Screening and synthesis of novel small molecules.
  • Assays to evaluate the compounds' ability to reactivate latent HIV-1.
  • Investigation of the compounds' mechanism of action on the BAF complex.

Main Results:

Related Experiment Videos

  • Identification of specific compounds that effectively reverse HIV-1 latency in cellular models.
  • Demonstration that these compounds modulate the activity of the BAF chromatin remodeling complex.
  • Evidence suggesting these compounds can lead to the clearance of the latent viral reservoir.

Conclusions:

  • Targeting the BAF chromatin remodeling complex is a promising strategy for reversing HIV-1 latency.
  • The developed compounds represent a potential new class of therapeutics for achieving a functional cure for HIV-1.
  • Further research is warranted to advance these compounds towards clinical application.